However, when treated with the combination of fluvastatin and avasimibe, the expression levels of ACAT2 were not significantly different from those seen in animals treated with a vehicle control, confirming that in the combination-treated animals, avasimibe effectively inhibited the expression of ACAT2 transcripts in breast tumors (Figure 3). Here, ACAT2 is linked to breast neoplasm.